Logo image of BCAL

CALIFORNIA BANCORP (BCAL) Stock Fundamental Analysis

USA - NASDAQ:BCAL - US84252A1060 - Common Stock

16.82 USD
-0.36 (-2.1%)
Last: 10/7/2025, 8:11:00 PM
16.82 USD
0 (0%)
After Hours: 10/7/2025, 8:11:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BCAL. BCAL was compared to 392 industry peers in the Banks industry. While BCAL is still in line with the averages on profitability rating, there are concerns on its financial health. BCAL is evaluated to be cheap and growing strongly. This does not happen too often!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BCAL had positive earnings in the past year.
In the past year BCAL had a positive cash flow from operations.
BCAL Yearly Net Income VS EBIT VS OCF VS FCFBCAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 20M 40M 60M 80M

1.2 Ratios

BCAL has a Return On Assets (0.79%) which is comparable to the rest of the industry.
With a Return On Equity value of 5.71%, BCAL is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
BCAL has a better Return On Invested Capital (2.17%) than 99.49% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BCAL is in line with the industry average of 2.46%.
The 3 year average ROIC (1.52%) for BCAL is below the current ROIC(2.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.79%
ROE 5.71%
ROIC 2.17%
ROA(3y)0.65%
ROA(5y)N/A
ROE(3y)5.41%
ROE(5y)N/A
ROIC(3y)1.52%
ROIC(5y)N/A
BCAL Yearly ROA, ROE, ROICBCAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2 4 6 8

1.3 Margins

The Profit Margin of BCAL (13.66%) is worse than 77.30% of its industry peers.
BCAL's Profit Margin has declined in the last couple of years.
BCAL has a Operating Margin of 54.68%. This is amongst the best in the industry. BCAL outperforms 99.74% of its industry peers.
In the last couple of years the Operating Margin of BCAL has grown nicely.
Industry RankSector Rank
OM 54.68%
PM (TTM) 13.66%
GM N/A
OM growth 3Y19.95%
OM growth 5YN/A
PM growth 3Y-42.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BCAL Yearly Profit, Operating, Gross MarginsBCAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BCAL is destroying value.
BCAL has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, BCAL has an improved debt to assets ratio.
BCAL Yearly Shares OutstandingBCAL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
BCAL Yearly Total Debt VS Total AssetsBCAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of -0.68, we must say that BCAL is in the distress zone and has some risk of bankruptcy.
With an excellent Altman-Z score value of -0.68, BCAL belongs to the best of the industry, outperforming 98.98% of the companies in the same industry.
BCAL has a debt to FCF ratio of 54.39. This is a negative value and a sign of low solvency as BCAL would need 54.39 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 54.39, BCAL is doing worse than 83.93% of the companies in the same industry.
A Debt/Equity ratio of 6.15 is on the high side and indicates that BCAL has dependencies on debt financing.
The Debt to Equity ratio of BCAL (6.15) is worse than 96.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.15
Debt/FCF 54.39
Altman-Z -0.68
ROIC/WACC0.59
WACC3.69%
BCAL Yearly LT Debt VS Equity VS FCFBCAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 0.04 indicates that BCAL may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.04, BCAL belongs to the top of the industry, outperforming 99.23% of the companies in the same industry.
BCAL has a Quick Ratio of 0.04. This is a bad value and indicates that BCAL is not financially healthy enough and could expect problems in meeting its short term obligations.
BCAL has a Quick ratio of 0.04. This is amongst the best in the industry. BCAL outperforms 99.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
BCAL Yearly Current Assets VS Current LiabilitesBCAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1B 2B 3B

8

3. Growth

3.1 Past

BCAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.95%, which is quite impressive.
The earnings per share for BCAL have been decreasing by -28.36% on average. This is quite bad
BCAL shows a strong growth in Revenue. In the last year, the Revenue has grown by 80.83%.
Measured over the past years, BCAL shows a very strong growth in Revenue. The Revenue has been growing by 37.61% on average per year.
EPS 1Y (TTM)63.95%
EPS 3Y-28.36%
EPS 5YN/A
EPS Q2Q%4200%
Revenue 1Y (TTM)80.83%
Revenue growth 3Y37.61%
Revenue growth 5YN/A
Sales Q2Q%99.64%

3.2 Future

Based on estimates for the next years, BCAL will show a very strong growth in Earnings Per Share. The EPS will grow by 50.42% on average per year.
Based on estimates for the next years, BCAL will show a quite strong growth in Revenue. The Revenue will grow by 18.55% on average per year.
EPS Next Y141.54%
EPS Next 2Y50.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year36.86%
Revenue Next 2Y18.56%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BCAL Yearly Revenue VS EstimatesBCAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 50M 100M 150M
BCAL Yearly EPS VS EstimatesBCAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.93, which indicates a very decent valuation of BCAL.
BCAL's Price/Earnings ratio is in line with the industry average.
BCAL is valuated cheaply when we compare the Price/Earnings ratio to 27.76, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 10.18, the valuation of BCAL can be described as very reasonable.
BCAL's Price/Forward Earnings is on the same level as the industry average.
BCAL is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.93
Fwd PE 10.18
BCAL Price Earnings VS Forward Price EarningsBCAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BCAL indicates a rather cheap valuation: BCAL is cheaper than 99.74% of the companies listed in the same industry.
75.77% of the companies in the same industry are more expensive than BCAL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.84
EV/EBITDA 4.03
BCAL Per share dataBCAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

BCAL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BCAL's earnings are expected to grow with 50.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y50.42%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BCAL!.
Industry RankSector Rank
Dividend Yield N/A

CALIFORNIA BANCORP

NASDAQ:BCAL (10/7/2025, 8:11:00 PM)

After market: 16.82 0 (0%)

16.82

-0.36 (-2.1%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-28 2025-07-28/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners57.67%
Inst Owner Change0%
Ins Owners24.1%
Ins Owner Change-0.29%
Market Cap546.99M
Analysts80
Price Target19.04 (13.2%)
Short Float %1.55%
Short Ratio3.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.56%
Min EPS beat(2)3.66%
Max EPS beat(2)27.45%
EPS beat(4)4
Avg EPS beat(4)33.05%
Min EPS beat(4)3.66%
Max EPS beat(4)87.43%
EPS beat(8)4
Avg EPS beat(8)0.77%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.08%
Max Revenue beat(2)-2.03%
Revenue beat(4)0
Avg Revenue beat(4)-4.17%
Min Revenue beat(4)-8.89%
Max Revenue beat(4)-2.03%
Revenue beat(8)0
Avg Revenue beat(8)-4.74%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.42%
EPS NY rev (1m)0%
EPS NY rev (3m)0.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.81%
Valuation
Industry RankSector Rank
PE 11.93
Fwd PE 10.18
P/S 2.39
P/FCF 8.84
P/OCF 8.77
P/B 1
P/tB 1.31
EV/EBITDA 4.03
EPS(TTM)1.41
EY8.38%
EPS(NY)1.65
Fwd EY9.82%
FCF(TTM)1.9
FCFY11.31%
OCF(TTM)1.92
OCFY11.4%
SpS7.04
BVpS16.84
TBVpS12.8
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.79%
ROE 5.71%
ROCE 20.83%
ROIC 2.17%
ROICexc 2.22%
ROICexgc 2.34%
OM 54.68%
PM (TTM) 13.66%
GM N/A
FCFM 27.04%
ROA(3y)0.65%
ROA(5y)N/A
ROE(3y)5.41%
ROE(5y)N/A
ROIC(3y)1.52%
ROIC(5y)N/A
ROICexc(3y)1.54%
ROICexc(5y)N/A
ROICexgc(3y)1.61%
ROICexgc(5y)N/A
ROCE(3y)15.77%
ROCE(5y)N/A
ROICexcg growth 3Y37.36%
ROICexcg growth 5YN/A
ROICexc growth 3Y36.52%
ROICexc growth 5YN/A
OM growth 3Y19.95%
OM growth 5YN/A
PM growth 3Y-42.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 6.15
Debt/FCF 54.39
Debt/EBITDA 25.73
Cap/Depr 8.18%
Cap/Sales 0.2%
Interest Coverage 2.01
Cash Conversion 47.67%
Profit Quality 197.92%
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -0.68
F-Score8
WACC3.69%
ROIC/WACC0.59
Cap/Depr(3y)28.31%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.57%
Cap/Sales(5y)N/A
Profit Quality(3y)372.76%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.95%
EPS 3Y-28.36%
EPS 5YN/A
EPS Q2Q%4200%
EPS Next Y141.54%
EPS Next 2Y50.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)80.83%
Revenue growth 3Y37.61%
Revenue growth 5YN/A
Sales Q2Q%99.64%
Revenue Next Year36.86%
Revenue Next 2Y18.56%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y81.16%
EBIT growth 3Y65.06%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.29%
FCF growth 3Y40.59%
FCF growth 5YN/A
OCF growth 1Y59.14%
OCF growth 3Y36.79%
OCF growth 5YN/A